Patents by Inventor Jared Andrew Forrester

Jared Andrew Forrester has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20140221428
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: April 22, 2014
    Publication date: August 7, 2014
    Applicant: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei LY, Garrett Thomas POTTER, Jared Andrew FORRESTER
  • Arylsulfonamide CCR3 antagonists
    Patent number: 8741894
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: March 17, 2011
    Date of Patent: June 3, 2014
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Garrett Thomas Potter, Jared Andrew Forrester
  • Arylsulfonamide CCR3 antagonists
    Patent number: 8658642
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: February 25, 2014
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Jared Andrew Forrester
  • ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20130217687
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: March 15, 2013
    Publication date: August 22, 2013
    Applicant: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei LY, Jared Andrew FORRESTER
  • Arylsulfonamide CCR3 antagonists
    Patent number: 8420639
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Grant
    Filed: April 21, 2010
    Date of Patent: April 16, 2013
    Assignee: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Jared Andrew Forrester
  • ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20110230487
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: March 17, 2011
    Publication date: September 22, 2011
    Inventors: Tai Wei LY, Garrett Thomas Potter, Jared Andrew Forrester
  • ARYLSULFONAMIDE CCR3 ANTAGONISTS
    Publication number: 20100273795
    Abstract: Provided herein are arylsulfonamides that are useful for modulating CCR3 activity, and pharmaceutical compositions thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of a CCR3-mediated disorder, disease, or condition.
    Type: Application
    Filed: April 21, 2010
    Publication date: October 28, 2010
    Applicant: Axikin Pharmaceuticals, Inc.
    Inventors: Tai Wei Ly, Jared Andrew Forrester